Epic’s lawsuit against Health Gorilla is less about one alleged data misuse scheme and more about a deeper fault line in healthcare interoperability: data can move faster than the rules governing it. Experts say this problem could force the industry to redefine the boundaries of access, accountability and trust in data sharing. The post Epic…
DENVER — On a bustling street corner one recent afternoon outside the offices of the Harm Reduction Action Center, employees of the education and advocacy nonprofit handed out free naloxone kits to passersby. Distributing the opioid reversal medication is essential to the center’s work to reduce fatal overdoses in the community. But how long the…
The Series C funding round was from The General Partnership, Index Ventures, General Catalyst and Andreessen Horowitz. The post Thatch Secures $108M, Reaches $1B Valuation appeared first on MedCity News.
AstraZeneca’s Calquence has expanded its FDA approval to include first-line treatment of mantle cell lymphoma. The regulatory decision makes Calquence the first BTK inhibitor approved as an initial treatment for this type of blood cancer. The post FDA Nod Paves Way for AstraZeneca Drug to Become New Standard of Care in Rare Blood Cancer appeared…
KFF Health News contributor Erin Rode discussed California prison heat protections on KVPR’s Central Valley Daily on Sept. 24. Click here to hear Rode on Central Valley Daily. Read Rode’s “California Eyes Prison Heat Protections That Fall Short of Workplace Standards.” KFF Health News chief Washington correspondent Julie Rovner discussed the removal of more than…
Natalie Schneider is CEO of Fort Health, a relatively new entrant into the children’s mental health market. Fort Health’s modus operandi is to partner with (i.e. market via) pediatricians to recruit patients. They are delivering integrated care and something called collaborative care…a newer model that has more frequent and shorter interventions and is more affordable….
Following Brexit, the funding infrastructure for new buyout funds in the UK has broken down. These new managers are now struggling to find anchor investors and offer an opportunity to the private sector to step in and secure attractive returns. The post The Opportunity being Missed in UK Healthcare Buyouts appeared first on MedCity News.
Sarepta’s Elevidys will remain on the market with a black box warning. But this gene therapy for Duchenne muscular dystrophy still faces commercial headwinds and analysts say the company has work to do to win over patients and investors. The post Sarepta Slashes Staff, Maps Path Forward for Gene Therapy and Narrower Pipeline appeared first…
NASHVILLE, Tenn. — Federal prosecutors sought a maximum prison sentence of nearly 20 years for the CEO of Pain MD, a company found to have given hundreds of thousands of questionable injections to patients, many reliant on opioids. It would have been among the longest sentences for a health care executive convicted of fraud in…
Significant shares of adults with multiple or complex health conditions, including cancer, lung disease, diabetes, cardiovascular disease, and mental health conditions say they struggle to pay their medical bills and access needed care and medication. These challenges fall hardest on uninsured adults who face greater costs and access challenges.